Optilume drug-coated balloon for anterior urethral stricture: 2-year results of the ROBUST III trial.
BJUI compass · 2024 · 52 citations · Karl Coutinho
Primary Chemoablation of Recurrent Low-Grade Intermediate-Risk Nonmuscle-Invasive Bladder Cancer With UGN-102: A Single-Arm, Open-Label, Phase 3 Trial (ENVISION).
The Journal of urology · 2025 · 38 citations · Sandip Prasad
One-Year Results for the ROBUST III Randomized Controlled Trial Evaluating the Optilume® Drug-Coated Balloon for Anterior Urethral Strictures.
The Journal of urology · 2022 · 77 citations · Karl Coutinho
Single-port versus multiport partial nephrectomy: a propensity-score-matched comparison of perioperative and short-term outcomes.
Journal of robotic surgery · 2023 · 47 citations · Mubashir Billah
The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
The Journal of urology · 2023 · 35 citations · Karl Coutinho
Evaluation of a Novel Single-Use Flexible Ureteroscope.
Journal of endourology · 2021 · 47 citations · Anika Ackerman
Prevalence and Risk Factors for Pharmacoresistance in Children With Focal Cortical Dysplasia-Related Epilepsy.
Neurology · 2022 · 53 citations · Phat Chang
Treatment of Low-grade Intermediate-risk Nonmuscle-invasive Bladder Cancer With UGN-102 ± Transurethral Resection of Bladder Tumor Compared to Transurethral Resection of Bladder Tumor Monotherapy: A Randomized, Controlled, Phase 3 Trial (ATLAS).
The Journal of urology · 2023 · 40 citations · Sandip Prasad